Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIK Immunotherapy in Stage III Colon Cancer
NCT02280278Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Oct 2014
- Primary completion
- Oct 2019
- Countries
- 1
01
Overview
A Phase 3 trial of unmodified CIK in colon cancer, sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
unmodified CIK
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT02280278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280278.